Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation (NCT03684811) | Forma Therapeutics, Inc. | 2018-11-01 |
Track Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas) automatically
Every clearance here is in the API, with alerts when new ones post.